2269 Share Price Performance
JP¥0
-3514.00 (-100.00%)
Price JP¥0
Fair ValueJP¥4,122.22
Share Pricen/a
Meiji Holdings Co., Ltd. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
2269 Community Narratives
AN
Fair Value
·Fair Value JP¥4.12k 10.2% undervalued intrinsic discount
Analysts Reaffirm Meiji Holdings Price Target as Valuation Metrics Stay Steady Amid Singapore Plans
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value
·Fair Value JP¥3.1k 19.4% overvalued intrinsic discount
Cost Pressures And Overseas Challenges Will Constrain Future Margins Despite Restructuring Efforts
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value JP¥4.3k 13.9% undervalued intrinsic discount
Structural Reforms And Wellness Focus Will Support Stronger Long Term Outlook
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Analysts Reaffirm Meiji Holdings Price Target as Valuation Metrics Stay Steady Amid Singapore Plans
Key Takeaways Strategic price adjustments and brand enhancements in the Food segment may counter raw material cost pressures, boosting revenue and margins. Expansion in B2B and international markets, coupled with production optimization, is likely to drive revenue growth and profitability.Read more
AN
JP¥4.12k
10.2% undervalued intrinsic discount
Fair Value
Revenue
2.02% p.a.
Profit Margin
5.51%
Future PE
18.92x
Price in 2029
JP¥4.73k
Cost Pressures And Overseas Challenges Will Constrain Future Margins Despite Restructuring Efforts
Catalysts About Meiji Holdings Meiji Holdings operates food and pharmaceutical businesses, including dairy, confectionery, nutrition products, prescription drugs and vaccines. What are the underlying business or industry changes driving this perspective?Read more
AN
JP¥3.1k
19.4% overvalued intrinsic discount
Fair Value
Revenue
1.28% p.a.
Profit Margin
5.07%
Future PE
15.85x
Price in 2029
JP¥3.57k
Structural Reforms And Wellness Focus Will Support Stronger Long Term Outlook
Catalysts About Meiji Holdings Meiji Holdings operates food and pharmaceutical businesses, with a focus on dairy, confectionery, nutrition products and prescription drugs including vaccines. What are the underlying business or industry changes driving this perspective?Read more
AN
JP¥4.3k
13.9% undervalued intrinsic discount
Fair Value
Revenue
2.77% p.a.
Profit Margin
5.93%
Future PE
18x
Price in 2029
JP¥4.95k
Trending Discussion
Recently Updated Narratives
AN
2269: York Expansion And Minority Stake Will Support Measured Long Term Prospects
Fair Value: JP¥4.12k 10.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Cost Pressures And Overseas Challenges Will Constrain Future Margins Despite Restructuring Efforts
Fair Value: JP¥3.1k 19.4% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Structural Reforms And Wellness Focus Will Support Stronger Long Term Outlook
Fair Value: JP¥4.3k 13.9% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Meiji Holdings Co., Ltd. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 14, 2026
- 169.66
- 30.21%
- 3.96%
- 17.6%
About 2269
- Founded
- 1916
- Employees
- 17231
- CEO
- WebsiteView website
Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectionery food products and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceuticals. The Food segment provides yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, prepared food, chocolate, gummy candy, sports nutrition, infant milk, liquid food, beauty products, feed, sugar, and corn sweeteners. The Pharmaceutical segment offers drugs for infectious and central nervous system disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
Recent 2269 News & Updates
